Studies have proven that CD8+ T cells in favorable acute myeloid leukemia (AML) facilitated the growth of leukemia stem/progenitor cells (LSPCs) by way of stimulating the autocrine manufacturing of necessary hematopoietic cytokines such as interleukin-3 (IL-3). The gene discussed is IL3; the disease is acute myeloid leukemia.